These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26477595)

  • 1. Genetics of coronary heart disease: towards causal mechanisms, novel drug targets and more personalized prevention.
    Orho-Melander M
    J Intern Med; 2015 Nov; 278(5):433-46. PubMed ID: 26477595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
    Vitali C; Khetarpal SA; Rader DJ
    Curr Cardiol Rep; 2017 Nov; 19(12):132. PubMed ID: 29103089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
    Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.
    Burgess S; Harshfield E
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):124-30. PubMed ID: 26910273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of coronary heart disease.
    Swerdlow DI; Holmes MV; Harrison S; Humphries SE
    Br Med Bull; 2012 Jun; 102():59-77. PubMed ID: 22577178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling new therapeutic targets of coronary artery disease by genetic approaches.
    Lee SE; Kim HS
    Circ J; 2015; 79(1):8-14. PubMed ID: 25501952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Causal Roles of Circulating Remnant Lipid Profile on Cardiovascular and Cerebrovascular Diseases: Mendelian Randomization Study.
    Si S; Hou L; Chen X; Li W; Liu X; Liu C; Li Y; Yuan T; Li J; Wang B; Li H; Xue F
    J Epidemiol; 2022 May; 32(5):205-214. PubMed ID: 33441507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.
    Zhan Y; Karlsson IK; Karlsson R; Tillander A; Reynolds CA; Pedersen NL; Hägg S
    Circ Res; 2017 Jul; 121(3):214-219. PubMed ID: 28515044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Association and Potential Mediators between Sarcopenia and Coronary Heart Disease: A Bidirectional Two-Sample, Two-Step Mendelian Randomization Study.
    He J; Huang M; Li N; Zha L; Yuan J
    Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
    Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
    J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps.
    Ference BA
    Curr Opin Lipidol; 2015 Dec; 26(6):566-71. PubMed ID: 26780009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.
    Song C; Burgess S; Eicher JD; O'Donnell CJ; Johnson AD
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.
    Holmes MV; Ala-Korpela M; Smith GD
    Nat Rev Cardiol; 2017 Oct; 14(10):577-590. PubMed ID: 28569269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
    Ward-Caviness CK; de Vries PS; Wiggins KL; Huffman JE; Yanek LR; Bielak LF; Giulianini F; Guo X; Kleber ME; Kacprowski T; Groß S; Petersman A; Davey Smith G; Hartwig FP; Bowden J; Hemani G; Müller-Nuraysid M; Strauch K; Koenig W; Waldenberger M; Meitinger T; Pankratz N; Boerwinkle E; Tang W; Fu YP; Johnson AD; Song C; de Maat MPM; Uitterlinden AG; Franco OH; Brody JA; McKnight B; Chen YI; Psaty BM; Mathias RA; Becker DM; Peyser PA; Smith JA; Bielinski SJ; Ridker PM; Taylor KD; Yao J; Tracy R; Delgado G; Trompet S; Sattar N; Jukema JW; Becker LC; Kardia SLR; Rotter JI; März W; Dörr M; Chasman DI; Dehghan A; O'Donnell CJ; Smith NL; Peters A; Morrison AC
    PLoS One; 2019; 14(5):e0216222. PubMed ID: 31075152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a): more interesting than ever after 50 years.
    Dubé JB; Boffa MB; Hegele RA; Koschinsky ML
    Curr Opin Lipidol; 2012 Apr; 23(2):133-40. PubMed ID: 22327610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of lipid-related therapeutic targets for coronary heart disease prevention using human genetics.
    Gordillo-Marañón M; Zwierzyna M; Charoen P; Drenos F; Chopade S; Shah T; Engmann J; Chaturvedi N; Papacosta O; Wannamethee G; Wong A; Sofat R; Kivimaki M; Price JF; Hughes AD; Gaunt TR; Lawlor DA; Gaulton A; Hingorani AD; Schmidt AF; Finan C
    Nat Commun; 2021 Oct; 12(1):6120. PubMed ID: 34675202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Hopewell JC; Malik R; Valdés-Márquez E; Worrall BB; Collins R;
    Eur Heart J; 2018 Feb; 39(5):354-359. PubMed ID: 29020353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth Weight, Cardiometabolic Factors, and Coronary Heart Disease: A Mendelian Randomization Study.
    Su S; Fan J; Yang Y; Yang C; Jia X
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1245-e1252. PubMed ID: 37246707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.
    Ference BA; Yoo W; Alesh I; Mahajan N; Mirowska KK; Mewada A; Kahn J; Afonso L; Williams KA; Flack JM
    J Am Coll Cardiol; 2012 Dec; 60(25):2631-9. PubMed ID: 23083789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From lipid locus to drug target through human genomics.
    van der Laan SW; Harshfield EL; Hemerich D; Stacey D; Wood AM; Asselbergs FW
    Cardiovasc Res; 2018 Jul; 114(9):1258-1270. PubMed ID: 29800275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.